These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14987837)

  • 21. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
    Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
    Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
    Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SAR studies of 1,5-diarylpyrazole-based CCK1 receptor antagonists.
    Gomez L; Hack MD; McClure K; Sehon C; Huang L; Morton M; Li L; Barrett TD; Shankley N; Breitenbucher JG
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6493-8. PubMed ID: 17933530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lipopolysaccharide on expression and characterization of cholecystokinin receptors in rat pulmonary interstitial macrophages.
    Xu SJ; Gao WJ; Cong B; Yao YX; Gu ZY
    Acta Pharmacol Sin; 2004 Oct; 25(10):1347-53. PubMed ID: 15456538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure guided evaluation of estrogen agonist and antagonist activities of some new tetrazolyl indole derivatives.
    Singh US; Shankar R; Yadav GP; Kharkwal G; Dwivedi A; Keshri G; Singh MM; Moulik PR; Hajela K
    Eur J Med Chem; 2008 Oct; 43(10):2149-58. PubMed ID: 18155810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists II: tuning of receptor selectivity and in vivo efficacy.
    Pippel M; Boyce K; Venkatesan H; Phuong VK; Yan W; Barrett TD; Lagaud G; Li L; Morton MF; Prendergast C; Wu X; Shankley NP; Rabinowitz MH
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6376-8. PubMed ID: 19815410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines.
    Mewshaw RE; Zhou D; Zhou P; Shi X; Hornby G; Spangler T; Scerni R; Smith D; Schechter LE; Andree TH
    J Med Chem; 2004 Jul; 47(15):3823-42. PubMed ID: 15239661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.
    Frost JM; Dart MJ; Tietje KR; Garrison TR; Grayson GK; Daza AV; El-Kouhen OF; Miller LN; Li L; Yao BB; Hsieh GC; Pai M; Zhu CZ; Chandran P; Meyer MD
    J Med Chem; 2008 Mar; 51(6):1904-12. PubMed ID: 18311894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
    Wan S; Coleman FH; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats.
    Cohen H; Kaplan Z; Matar MA; Buriakovsky I; Bourin M; Kotler M
    Depress Anxiety; 2004; 20(3):139-52. PubMed ID: 15487014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
    Hayes MR; Savastano DM; Covasa M
    Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
    De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G
    ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Turned dipeptoids as potent and selective CCK(1) receptor antagonists.
    Martín-Martínez M; De La Figuera N; Latorre M; Herranz R; García-López MT; Cenarruzabeitia E; Del Río J; González-Muñiz R
    J Med Chem; 2000 Oct; 43(20):3770-7. PubMed ID: 11020292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholecystokinin-8 increases Fos-like immunoreactivity in the brainstem and myenteric neurons of rats through CCK1 receptors.
    Gulley S; Sharma SK; Moran TH; Sayegh AI
    Peptides; 2005 Sep; 26(9):1617-22. PubMed ID: 16112401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel 5-HT3 antagonists. Indole oxadiazoles.
    Swain CJ; Baker R; Kneen C; Moseley J; Saunders J; Seward EM; Stevenson G; Beer M; Stanton J; Watling K
    J Med Chem; 1991 Jan; 34(1):140-51. PubMed ID: 1992112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
    Ganellin CR; Bishop PB; Bambal RB; Chan SM; Leblond B; Moore AN; Zhao L; Bourgeat P; Rose C; Vargas F; Schwartz JC
    J Med Chem; 2005 Nov; 48(23):7333-42. PubMed ID: 16279793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activity.
    Zhang P; Bao L; Zuckett JF; Jia ZJ; Woolfrey J; Arfsten A; Edwards S; Sinha U; Hutchaleelaha A; Lambing JL; Hollenbach SJ; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2004 Feb; 14(4):989-93. PubMed ID: 15013007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
    Dong M; Liu G; Pinon DI; Miller LJ
    Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
    Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
    J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
    Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.